It is reported that EF2 has been found to be highly expressed in a variety of malignant tumors, including human gastrointestinal cancers [18], lung adenocarcinoma [19], ovary cancer [20], hepatocellular carcinoma [21] and soft-tissue sarcomas [22]. This evidence concerns the gene EEF2 and lung adenocarcinoma.